Home / Healthcare / Cholera Pipeline

Cholera– Pipeline Review, 2019

Report Format: PDF | Published Date: Ongoing | Report ID: FBI101291 | Status : Pipeline

1. Introduction

1.1. Report Overview

2. Cholera- Overview

3. Executive Summary

4. Cholera: Pipeline Assessment

    4.1. By Stage of Development

    4.2. By Route of Administration

    4.3. By Drug Class

    4.4. By Molecule Type

    4.5. By Therapy Area / Indication

    4.6. By Drug Target

    4.7. By Sponsor

5. Cholera: Company & Drug Profiles

    5.1. Clinical Stage

        5.1.1. rBS-WC vaccine – International Vaccine Institute

            5.1.1.1. Company Overview

            5.1.1.2. Product Description

            5.1.1.3. R&D Status & Development Activities

            5.1.1.4. Mechanism of Action

            5.1.1.5. Molecule Type

            5.1.1.6. Stage of Development

            5.1.1.7. Indications

            5.1.1.8. Route of Administration

            5.1.1.9. Funding

        5.1.2. HL-OCV – International Centre for Diarrhoeal Disease Research

            5.1.2.1. Company Overview

            5.1.2.2. Product Description

            5.1.2.3. R&D Status & Development Activities

            5.1.2.4. Mechanism of Action

            5.1.2.5. Molecule Type

            5.1.2.6. Stage of Development

            5.1.2.7. Indications

            5.1.2.8. Route of Administration

            5.1.2.9. Funding

        5.1.3. BMB72 – Massachusetts General Hospital

            5.1.3.1. Company Overview

            5.1.3.2. Product Description

            5.1.3.3. R&D Status & Development Activities

            5.1.3.4. Mechanism of Action

            5.1.3.5. Molecule Type

            5.1.3.6. Stage of Development

            5.1.3.7. Indications

            5.1.3.8. Route of Administration

            5.1.3.9. Funding

        5.1.4. Others

    5.2. Preclinical

        5.2.1. Company Overview

        5.2.2. Product Description

        5.2.3. R&D Status & Development Activities

        5.2.4. Mechanism of Action

        5.2.5. Molecule Type

        5.2.6. Indications

        5.2.7. Route of Administration

        5.2.8. Funding

6. Cholera: An Overview on Dormant & Discontinued Pipeline Candidates

    6.1. Overview

    6.2. Product Description

    6.3. Reason for Discontinuation

7. Cholera: Additional Key Insights

    7.1. Epidemiology Overview: Cholera

    7.2. Current Market Scenario: Cholera Treatment

8. Cholera: News, Press Releases and Conference Details

  • Global
  • 2018
  • 2014-2018
  • PRICE
  • $ 2050
    $ 4150
    $ 6150
    Pre Book

Healthcare Clients